UC San Diego Researchers Receive Funding to Pursue Novel Stem Cell-based Treatments
July 20, 2018
…therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.
Your search for “Heart and Lung Disease” returned 113 results
Give and Make
April 12, 2018
…transplants of kidneys, livers, hearts and lungs. Someone new is added to a wait list every 10 minutes. More than 120,000 adults and children are currently on transplant wait lists. They are not getting shorter. Since the launch of its organ transplant program 50 years ago, UC San Diego School…
NIH Awards Researchers $3.1 Million Grant to Improve Treatment of Common Pediatric Heart Condition
August 26, 2019
An international team of researchers received a five-year, $3.1 million grant from the National Institutes of Health to discover new and better ways to treat a pediatric congenital heart condition known as tetralogy of Fallot, which affects a total of 85,000 individuals in the US.
Not Skipping a Beat: Sulpizio Cardiovascular Center Again Among Nation’s Best
September 18, 2014
UC San Diego Sulpizio Cardiovascular Center (SCVC) has been named among “100 Hospitals with Great Heart Programs” by Becker’s Hospital Review, a business and legal news publication for hospital and health system leadership.
The Un-appeal of Banana: Liquid E-Cigarette Flavorings Measurably Injure Lungs
December 14, 2020
UC San Diego researchers report chemicals used for flavor in e-cigarette liquid negatively affect specialized proteins that support immune system.
Targeting Molecular Pathway that Causes Pulmonary Arterial Hypertension
May 6, 2022
UC San Diego researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.
New Congenital Heart Disease Program Treats Patients with Complex Cardiac Needs
February 11, 2019
The Adult Congenital Heart Disease Program at UC San Diego Health is the only one in the region to provide a multi-disciplinary team with extensive knowledge in congenital heart disease and help patients transition from pediatric care to adult care.
Excess Neuropeptides Disrupt Lung Function in Infant Disease and COVID-19
March 17, 2022
UC San Diego study shows neuroendocrine cells in the lungs drive a developmental lung disease, and a similar brain-lung interaction may contribute to COVID-19 symptoms. The findings suggest neuropeptides may be a promising therapeutic target for conditions with excess lung fluid.
Out of Thin Air
August 27, 2020
…friends who suffer from lung disease reunite while seeking treatment at UC San Diego Health A lifelong athlete, Jillian Queri knew something was terribly wrong one morning while living abroad in Australia when, while surfing, she began struggling to breathe and almost drowned. In a hospital emergency department, Jillian learned…
UC San Diego Health Revives Non-Beating Donor Heart for Successful Transplantation
September 15, 2020
UC San Diego Health is the first hospital on the West Coast to perform heart transplant surgery from a donor after circulatory death using a new portable organ care system. The investigational procedure could significantly decrease transplant waiting list times and improve patient outcomes.
